scholarly journals Neonatal COVID-19: a clinical case report from the Democratic Republic of Congo (DRC)

2020 ◽  
Author(s):  
Serge ZIGABE ◽  
Etienne Kajibwami ◽  
Guy-Quesney Mateso ◽  
Benjamin Ntaligeza
Keyword(s):  
Case Report ◽  
World Health Organization ◽  
Clinical Case ◽  
Democratic Republic ◽  
Democratic Republic Of Congo ◽  
World Health ◽  
Wuhan City ◽  
Republic Of Congo ◽  
The World ◽  
Health Organization

Abstract COVID-19 started as a cluster of pneumonia cases in Wuhan City, the Province of Hubei, China, in December 2019. It spread to many regions of China, outside of China and was declared a pandemic by the World Health Organization (WHO) on March 11th, 2020. Initially Africa had no case and now the continent is reporting an increasing number of confirmed cases in an exponential manner (1,2).

Treatment Options in COVID-19: The Role of Bioavailable Antiviral Ribonucleoside Analog on NHC in vitro

2020 ◽  
Author(s):  
Lara Bittmann
Keyword(s):  
World Health Organization ◽  
Clinical Picture ◽  
Treatment Options ◽  
World Health ◽  
Wuhan City ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

On December 31, 2019, WHO was informed of cases of pneumonia of unknown cause in Wuhan City, China. A novel coronavirus was identified as the cause by Chinese authorities on January 7, 2020 and was provisionally named "2019-nCoV". This new Coronavirus causes a clinical picture which has received now the name COVID-19. The virus has spread subsequently worldwide and was explained on the 11th of March, 2020 by the World Health Organization to the pandemic.

Impact OF Covid-19 on Several Industries in Context with the Dialysis Industry

2021 ◽  
Vol 8 (2) ◽  
pp. 01-03
Author(s):  
Ashish Gujrathi
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
World Health ◽  
Healthcare Sector ◽  
Growth Opportunities ◽  
Wuhan City ◽  
First Case ◽  
The World ◽  
New Challenges ◽  
Health Organization

Coronavirus (COVID-19) was recognized in late December in Hubei province of Wuhan city in China. This highly contagious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from humans to humans. After the first case in Wuhan, the disease rapidly spread to other parts of the globe. On March 11, 2020, the World Health Organization (WHO) made an assessment that COVID-19 can be characterized as a pandemic. Thus, social-distancing became an important measure to stop the spread of this disease. Various countries across the world adopted nationwide lockdowns. This led to a completely new scenario for the world, where every business in each industry faced new challenges and witnessed new opportunities. Similarly, the medical personal protective industry, a vital part of the healthcare sector, also witnessed new growth opportunities.

scholarly journals A Case of Polyneuropathy Following a Single Dose of Diethylcarbamazine and Albendazole During Mass Administration of Drug - A Case Report

1970 ◽  
Vol 1 (1) ◽  
pp. 56-58
Author(s):  
SC Kohli ◽  
UK Shrestha ◽  
VM Alurkar ◽  
A Maskey ◽  
M Parajuli ◽  
...  
Keyword(s):  
Abdominal Pain ◽  
Single Dose ◽  
Case Report ◽  
Side Effects ◽  
World Health Organization ◽  
Mass Drug Administration ◽  
World Health ◽  
Medical Sciences ◽  
The World ◽  
Health Organization

The global program to eliminate Lymphatic Filariasis created by The World Health organization in 1997 is based on mass administration of single annual doses of diethylcarbamazine ( DEC) plus albendazole in non African regions and of albendazole plus ivermectin in Africa. The usual side effects of DEC treatment include fever, chills, arthralgia, headaches, nausea, and vomiting. Albendazole is associated with relatively few side effects consisting of occasional nausea, vomiting, abdominal pain, headache, reversible alopecia, elevated aminotransferases and rarely leucopenia and rash. We report a case of polyneuropathy in a young individual following DEC and albendazole during mass drug administration. Keywords: Albendazole; DEC; Polyneuropathy. DOI: http://dx.doi.org/10.3126/njms.v1i1.5800   Nepal Journal of Medical Sciences. 2012; 1(1): 56-58

scholarly journals Ebola haemorrhagic fever in Gabon and the Republic of Congo

2002 ◽  
Vol 6 (1) ◽  
Author(s):  
A C de Benoist
Keyword(s):  
World Health Organization ◽  
World Health ◽  
Haemorrhagic Fever ◽  
Republic Of Congo ◽  
The World ◽  
Republic Of The Congo ◽  
The Republic ◽  
Health Organization

As of 1 January, the World Health Organization (WHO) has reported 32 cases of Ebola haemorrhagic fever, including 23 deaths, in Gabon and the Republic of the Congo (1). Fifteen cases have been laboratory confirmed, and 17 have been linked epidemiologically. Twenty of the cases were detected in Gabon and 12 in the neighbouring villages of the Republic of Congo. An additional seven suspected cases in Gabon and two suspected cases in the Republic of Congo are under investigation.

scholarly journals The Covid-19 Between State of Emergency and Exception in Italy and Its Consequences on Human Rights

2020 ◽  
Vol 3 (2) ◽  
pp. 139
Author(s):  
Pina Sodano Omizzolo
Keyword(s):  
Human Rights ◽  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Social Consequences ◽  
World Health ◽  
Wuhan City ◽  
State Of Emergency ◽  
The World ◽  
Health Organization

In mid-December 2019, several atypical cases of pneumonia were detected in hospitals in Wuhan City – Hubei Province – in Inner China. It turns out that the first patients had already fallen ill in early December or even mid-November. However, only on the last day of the year 2019, Chinese doctors were able to officially identify a new virus in a 41-year-old patient admitted 5 days earlier. The virus belongs to the class of “coronavirus”, the same to which the SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome) viruses belong. It is initially baptized 2019-nCov, or “new 2019 coronavirus”. In February, the official name assigned to the virus is Sars-COV-2 and the associated disease is named COVID-19. The outbreak took on considerable proportions in China and then spread to the rest of the world, leading the World Health Organization to declare the infection a “pandemic” on 11 March 2020. The containment strategies applied in the most affected countries have proved to be very different in effectiveness, to the point that the lethality of the virus appears very different from country to country. This difference in impact has led to different legal, economic and social consequences.

scholarly journals Clinical diagnostic and treatment of COVID 19 of bilateral pneumonia: Case report

2021 ◽  
Vol 11 (2-S) ◽  
pp. 1-3
Author(s):  
A Otljanski ◽  
K Kipevska
Keyword(s):  
Case Report ◽  
Virus Infection ◽  
World Health Organization ◽  
World Health ◽  
Clinical State ◽  
Complex Treatment ◽  
Pneumonia Case ◽  
Corona Virus ◽  
The World ◽  
Health Organization

In 2019 year the world was attacked with corona virus (SARS-CoV-2) and in march 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic.The symptoms and clinical state in this COVID-19 infection was different, from asymptomatic to mild and severe symptoms, which presented different form of disease: mild, moderate or severe, with or without complications. We presented case with COVID 19 pneumonia as one of the form of COVID infection, with diagnosis, treatment and all investigations we done in our hospital. With complex treatment of this virus infection we successful improved the clinical state of patients with COVID 19 pneumonia. Keywords: coronavirus, SARS-CoV-2, COVID-19, COVID 19 pneumonia

scholarly journals INFLAMMATORY MYOFIBROBLASTIC TUMORS IN THE PECULIAR CONTEXT OF THE POSTPARTUM CASE REPORT

2021 ◽  
Vol 9 (03) ◽  
pp. 607-611
Author(s):  
Khalloufi C. ◽  
◽  
Ibnoulkhatib S. ◽  
El Kebir A. ◽  
Karkouri M. ◽  
...  
Keyword(s):  
Case Report ◽  
Cesarean Section ◽  
World Health Organization ◽  
Rare Complication ◽  
Malignant Neoplasm ◽  
World Health ◽  
Pathological Examination ◽  
The World ◽  
Inflammatory Myofibroblastic Tumors ◽  
Health Organization

The debate persists about the inflammatory or tumoral, benign or malignant nature of the Inflammatory myofibroblastic tumors (TMI). Radioclinically, they can mimic a malignant neoplasm, although they are classified as intermediate by the World Health Organization (WHO). The diagnosis is almost always made by pathological examination. The treatment is poorly codified but the management is usually surgical. The removal of these tumors is a challenge when the mass is developed at the expense of or in the vicinity of noble organs. Several therapies have been tested to overcome the limitations of surgery, the results are variable. These tumors rarely affect the digestive tract. We propose the study of a case of myofibroblastic tumor developed at the expense of the omentum, five months after a cesarean section, in order to try to determine if it is a rare complication of the postpartum or a fortuitous combination.

scholarly journals Impact of COVID-19 on several industries in context with the telehealth and telemedicine industry

2021 ◽  
Vol 2 (4) ◽  
pp. 01-02
Author(s):  
Ashish Gujrathi
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
World Health Organization ◽  
Hubei Province ◽  
World Health ◽  
Growth Opportunities ◽  
Wuhan City ◽  
First Case ◽  
The World ◽  
New Challenges ◽  
Health Organization

Coronavirus (COVID-19) was recognized in late December in Hubei province of Wuhan city in China. This highly contagious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from humans to humans. After the first case in Wuhan, the disease rapidly spread to other parts of the globe. On March 11, 2020, the World Health Organization (WHO) made an assessment that COVID-19 can be characterized as a pandemic. Thus, social-distancing became an important measure to stop the spread of this disease. Various countries across the world adopted nationwide lockdowns. This led to a completely new scenario for the world, where every business in each industry faced new challenges and witnessed new opportunities. Similarly, the telehealth and telemedicine industry has also witnessed newer growth opportunities.

A Review on Coronavirus

2021 ◽  
pp. 253-255
Author(s):  
Mahesh. B. Chavan ◽  
Durgesh Tarade ◽  
Kushan. H. Pagare ◽  
Ritik. S. Jain
Keyword(s):  
World Health Organization ◽  
Sore Throat ◽  
World Health ◽  
Wholesale Market ◽  
Wuhan City ◽  
Global Pandemic ◽  
First Case ◽  
The World ◽  
Health Organization

Coronavirus disease also termed as covid-19 or SARS-COV-2 infection has been declared as global pandemic disease by World Health Organization (WHO). The first case of covid-19 is reported at the local Huanan Seafood wholesale market in Wuhan city in Hubei in central chain at last of 2019. Covid-19 is rapidly spread throughout the world since December – 2019 from Wuhan city of China. Covid-19 patient has various symptoms like fever, cough, sore throat, breathlessness, fatigue and others. It is very necessary to identify the cases of covid-19 as soon as possible and isolate the suspected people and confirmed cases of Covid-19 to prevent the infection to other peoples.

Sign in / Sign up

Export Citation Format

Share Document